What Is Addyi, and Why Does It Matter? Addyi (flibanserin) is a nonhormonal prescription pill that is now approved by the FDA to treat low sexual desire in women younger than 65, including those who ...

In the often unspoken world of female sexual health, a revolution has started, and it began with the introduction of a unique medication called Addyi. Traditionally, when we think of sexual ...

The Food and Drug Administration (FDA) is considering possible regulatory action, due to a spike in reported adverse events associated with the drug Addyi (flibanserin), which is indicated for ...

Addyi is the first and only FDA-approved, hormone-free pill clinically proven to treat low sexual desire in women RALEIGH, N.C., July 24, 2025 /PRNewswire/ -- Sprout Pharmaceuticals today announced ...

Earlier this month the makers of, Addyi—the beleaguered drug many have misguidedly labeled the “female Viagra,”—announced that the little pink pill is relaunching after years of controversy, a ...

Viagra, the little blue pill, has been a household name for more than a generation. And now women's sexual health is finally entering the long-overdue conversation. The FDA recently approved the use ...

Share on Pinterest Addyi, sometimes referred to as “female Viagra,” is now approved for use to treat low sex drive in postmenopausal women. MoMo Productions/Getty Images The FDA expanded its approval ...

RALEIGH, N.C., Jan. 29, 2026 /PRNewswire/ -- Sprout Pharmaceuticals today announced that Addyi® has been named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards, one of the ...

Credit: Sprout Pharmaceuticals The approval was based on a randomized, double-blind, placebo-controlled phase 3 trial, which included 447 postmenopausal women with acquired, generalized HSDD.

A decade ago, Cindy Eckert struggled to convince skeptics about a drug for premenopausal women. Lately, her business is booming. A decade ago, Cindy Eckert struggled to convince skeptics about a drug ...